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Abstract:  The purpose of this paper is to determine what factor affect trust in scientists and food 
manufacturers, and to examine how trust in these institutions affects public support for 
biotechnology.  Data from the U.S. Biotechnology Study reveal that benefits from biotechnology 
and expectations of trustworthiness are correlated with trust in scientists, but benefits and costs 
of biotechnology, and expectations of trustworthiness and competence of biotechnology 
institutions, are important determinants of trust in food manufacturers.  The data also reveal that 
trust in scientists and food manufacturers has a large and important effect on public support for 
biotechnology, but trust in scientists is more important for public support than trust in food 
manufacturers.   
 
JEL Classifications: L65, Q18 
 
 
 
* This research was supported in part by the Missouri Agricultural Experiment Station. 
Trust in Scientists and Food Manufacturers, with Implications for 
the Public Support of Biotechnology 
Introduction 
We might expect a relationship between the trust people place in biotechnology 
institutions and the support they are willing to give to biotechnology research and 
commercialization.  Indeed, many scholars believe that low public support for biotechnology is a 
sign of a lack of public trust (Brom, 2000; Hampel, Pfenning, and Peter, 2001; see also Slovic, 
1993).  One reason offered is that consumers perceive that biotechnology institutions have two 
biases – a reporting bias, which is an incentive to overstate benefits and understate risks, and a 
knowledge bias, which is an inability to fully anticipate all contingencies – when publicly 
communicating the risks and benefits of biotechnology research (Eagly, Wood, and Chaiken, 
1978; Kasperson, 1986; Renn and Levine, 1991; Dholakia and Sternthal, 1997; Peters, Covello, 
and McCallum, 1997).  These biases are a reflection of the public's perceptions of 
trustworthiness (e.g., reporting bias) and competence (e.g., knowledge bias), which are 
recognized within the literature as necessary for trust formation (Hardin, 2004).  
Although there is a theoretical basis for linking trust to public support for biotechnology 
and genetic engineering, the empirical evidence is mixed.  For example, experiments by Frewer 
and Shepherd (1994) and Finlay, Morris, Londerville, and Watts (1999) find little, if any, effect 
of trust on public support, while survey research by Rosati and Saba (2000) and Siegrist (2000) 
show a positive but small effect of trust on public support.  Recently, James (2003) argued that 
the low measured effect of trust on public support is explained by the fact that trust is 
endogenously determined with public support.  When this endogeneity is controlled for, public 
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trust of biotechnology institutions is shown to have a large effect on public support for the 
genetic modification of crop plants and the application of biotechnology in food production.  
This paper extends the James (2003) study by separately modeling the trust in scientists 
developing the technology and agribusinesses commercializing it and by showing how trust in 
these particular institutions affects the general support by the public for biotechnology.  
 
Trust in Biotechnology Institutions 
Trust is "the willingness of a party to be vulnerable to the actions of another party based 
on the expectation that the other will perform a particular action important to the trustor" (Mayer, 
Davis, and Schoorman, 1995, p. 712).  According to this definition, willingness, vulnerability, 
and expectations are keys aspects of trust and trust formation.  Willingness reflects confidence 
that correctly trusting will result in benefits for the truster.  Vulnerability reflects the perception 
that losses can arise when trust us misplaced – that is, when trust in placed in someone who 
might (willingly or unwillingly) exploit that trust.  Expectations entail a belief in the 
trustworthiness and competence of the person or entity in whom trust is placed, both of which 
are necessary for trust.  For instance, Hardin (2004, p. 8) says that "trust depends on two quite 
different dimensions: the motivation of the potentially trusted person to attend to the truster's 
interests and his or her competence to do so."  
James (2002) develops a model linking willingness, vulnerability, and expectations to 
trust. In his model, individuals trust when the expected benefits from correctly trusting exceed 
the expected losses from mistrusting.  The expected benefits exceed expected losses as the losses 
from mistrusting decrease, the gains from correctly trusting increase, and the expectation that 
trust will not be exploited increases.  The expectation of being exploited is assumed to be a 
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function of the trustworthiness and competence of the person or institution in whom trust is 
placed.  Although previous research has linked these factors to trust (e.g., Hunt and Frewer, 
2001; Peters, Covello, and McCallum, 1997; Kasperson, Golding, and Tuler, 1992), this paper 
uses a national survey of U.S. household to examine how perceived benefits, costs, and 
expectations of trustworthiness and competence affect trust in specific biotechnology 
institutions, namely scientists and agribusiness food manufacturers. 
Public trust of biotechnology institutions can be modeled by the binary dependent 
variable equation 
(1) iii ZT εγ +′= , 
where  if we observe trust, and 1=iT 0=iT  if we observe no trust, Zi represents characteristics of 
individual i, γ is a vector of parameters, and iε  represents unknown characteristics affecting 
trust.  We observe trust when the expected benefits of correctly trusting exceed the expected 
costs of mistrusting, which is a function of perceived benefits from correctly trusting, perceived 
losses from mistrusting, and expectations of trustworthiness and competence.  Therefore, the set 
of explanatory variables, Zi, should include elements representing individual i's assessments of 
the potential benefits and costs of biotechnology, the trustworthiness and competence of 
biotechnology institutions, and other control factors.  The probability that individual i will trust 
biotechnology institutions is expected to increase as the perceived benefits from biotechnology 
increase, the risks or costs of using biotechnology decrease, and the likelihood that trust will not 
be exploited increases through untrustworthiness or incompetence, other things being equal.  
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Public Support for Biotechnology and Trust 
Studies have identified a number of factors affecting public support for biotechnology, 
such as perceived risks and benefits, uncertainty, the level of understanding of biotechnology, 
and moral beliefs about biotechnology.  Although public trust of biotechnology institutions has 
been recognized as a factor, some scholars have argued that it is not an important factor (e.g., 
Rosati and Saba, 2000; Siegrist, 2000).  
James (2003) showed that previous empirical studies failed to account for the 
endogeneity of trust in models of public support, thus accounting for the fact that trust is often 
not found to be important.  In other words, suppose we model the effect of trust and other factors 
on public support for biotechnology by the equation 
(2) iiii uTXS ++′= δβ , 
where Si is a measure of public support, β is a vector of parameters, Xi is a vector of explanatory 
variables other than trust, Ti is a dummy variable equal to one if the individual trusts 
biotechnology institutions and zero otherwise, δ is a coefficient measuring the effect of trust on 
public support, ui is an error term, and i is an index for individuals Ni K1= .  If Ti in equation (2) 
is modeled by equation (1), the error terms εi and ui will be correlated.  The implication is that 
trust must be treated as an endogenous rather than exogenous variable in equation (2), otherwise 
an estimation of δ will be biased.  According to James (2003), one way of correcting for the 
endogeneity of trust is to replace Ti in equation (2) with an instrumental variable expected to be 
correlated with Si but not correlated with the error term ui.  This is done as follows: Equation (1) 
is estimated with a Probit analysis.  Then the predicted probabilities of Ti, denoted as , are 
inserted in equation (2) in place of T
iTˆ
i, resulting in the following corrected version of equation 
(2): 
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(3) . iiii TXS μδβ ++′= ˆ
This equation provides a means of examining the unbiased effect of trust on public 
support for biotechnology.  James (2003) found that trust in biotechnology institutions is 
positively correlated with public support for biotechnology.  Accordingly, it is expected that an 
estimation of equation (3) will show that both trust in scientists and trust in food manufacturers 
will have a positive impact on public support for biotechnology, controlling for other factors 
expected to affect support. 
 
Methods 
Data for this study comes from the United States Biotechnology Study, 1997-1998.  This 
dataset was created from telephone interviews of 1,067 randomly sampled U.S. citizens, 18 years 
of age and older, between November 1997 and February 1998 (see Miller, 2000).  In this sample, 
58.7 percent of respondents had at least some post high school education, 49.8 percent of 
respondents were male, 54.7 percent of respondents were married, and the average respondent 
was approximately 45 years old. Because the data for this study comes from a pre-existing, 
publicly available dataset, variable and proxy selection are limited by the type and quality of 
questions utilized in the survey.  Table 1 presents a description of all variables used in this study.  
 
The Trust Model 
Equation (1) describes the relationship between trust and factors expected to affect trust.  
Trust in scientists is proxied by a dichotomous variable equal to one if respondents placed a lot 
or some trust in a statement by university scientists about biotechnology.  Trust in food 
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manufacturers is a dichotomous variable equal to one if respondents placed a lot or some trust in 
a statement about biotechnology by food manufacturers.  As shown in Table 1, more than 90 
percent of respondents reported at least some trust in university scientists, while 55 percent of 
respondents placed at least some trust in food manufacturers.  Moreover, the standard deviation 
of trust in scientists is smaller than the standard deviation of trust in food manufacturers, even 
after controlling for the variable means.  This suggests not only that respondents place higher 
trust in scientists than food manufacturers, but also that few factors will likely explain variations 
in trust in scientists, since such trust is high and variability it low, at least relative to trust in food 
manufacturers.  
In order to examine factors reflecting perceived benefits, costs, and expectations of 
trustworthiness and competence on trust, a Probit model is estimated in which trust in scientists 
and trust in food manufacturers are treated as dependent variables.  Perceptions of benefits of 
biotechnology are proxied by variables representing respondent beliefs about whether 
biotechnology will improve our way of life, whether biotechnology will likely reduce 
environmental pollution, and whether biotechnology will reduce world hunger.  In each case, an 
increase in the variable is expected to have a positive impact on trust in both scientists and food 
manufacturers.  Perceptions of costs arising from biotechnology are proxied by variables 
representing respondent beliefs about whether biotechnology and genetic engineering is risky, 
whether new diseases are likely to emerge because of biotechnology research, and whether 
biotechnology will reduce the range of fresh foods available.  In each of these cases, an increase 
in each variable is expected to have a negative impact on trust.   
The trustworthiness of biotechnology institutions is proxied by a variable indicating 
whether respondents believe current regulations are sufficient to protect people from risks and a 
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variable indicating whether respondents believe the biotechnology industry can self-regulate.  
Each of these variables is expected to be positively correlated with improved trustworthiness of 
university scientists and food manufacturers, suggesting that they should positively affect trust in 
these biotechnology institutions.  Competence is proxied by a variable indicating whether 
respondents agree that biotechnology is too complex to be adequately regulated and by a variable 
indicating whether respondents agree that it is not worth labeling genetically-modified (GM) 
food.  Because a reduction in perceived competence is expected to lower trust, the variable 
measuring complexity and regulation is expected to be negative, while the variable representing 
attitudes toward food labeling is expected to be positive.  (In the latter case, the justification is 
that if respondents are not concerned about the competence of biotechnology institutions, they 
may not perceive a need to distinguish between GM and non-GM foods.) 
 
The Support Model 
Equation (3) describes the relationship between public support and trust, controlling for 
the expected endogeneity of trust and other factors expected to affect support.  Public support for 
biotechnology is proxied by a dichotomous variable equal to one if respondents expressed 
support rather than opposition to biotechnology in agriculture and food production.  As shown in 
Table 1, approximate three quarters of respondents expressed support for biotechnology.  
Siegrist (2000) and Rosati and Saba (2000) reported that increases in perceived risks tend 
to reduce public acceptance, while increases in the expected benefits of biotechnology research 
improve public acceptance (see also Wolt and Peterson, 2000; Hampel, Pfenning, and Peters, 
2000).  Therefore, we include variables representing respondent beliefs that biotechnology will 
improve life and that biotechnology is risky.  Additionally, Rosati and Saba (2000) found that 
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uncertainty regarding biotechnology and moral beliefs affected public acceptance.  Therefore, a 
variable measuring the strength of the respondent's religious beliefs is included, as well as 
variables expected to reflect the degree of uncertainty a respondent feels towards biotechnology.  
These include a variable indicating beliefs about how important biotechnology is to the 
respondent, a variable measuring how informed the respondent is on biotechnology, a variable 
indicating whether the respondent has negative feelings towards biotechnology, and a variable 
indicating the level of understanding the respondent has about biotechnology and genetic 
engineering. 
 
Results 
Table 2 presents the results of the Probit analysis of equation (1), in which trust in 
scientists and trust in food manufacturers are regressed on variables representing benefits, costs, 
trustworthiness, and competence – factors expected to be important for trust.  Table 3 presents 
the results of the Probit analysis of equation (3), in which a measure of public support for 
biotechnology is regressed on predicted trust in scientists and food manufacturers, controlling for 
other factors expected to affect support.  The estimated slope, which represents the change in the 
probability of the dependent variable for a unit change in the explanatory variable, is calculated 
by multiplying the estimated coefficient by the average density function of the standard normal 
distribution evaluated for each observation (Greene, 2000).  
Table 2 reveals that few variables affect trust of scientists.  Indeed, the only variables 
significantly correlated with trust in scientists are perceptions of whether biotechnology will 
improve life and beliefs that current regulations are sufficient to regulate biotechnology 
institutions.  That is, perceived benefits and expectations of trustworthiness alone are key factors 
 8
explaining trust in scientists.  However, the effect of these two variables is relatively small, 
improving trust by approximately five percent each.   
In contrast, trust in food manufacturers is affected by variables representing perceived 
benefits, perceived costs, expectations of trustworthiness, and expectations of competence, as 
expected.  For example, perceptions that biotechnology will result in improved life, reduced 
pollution, and reduced world hunger increase trust in food manufacturers by 8.7 percent, 5.6 
percent, and 9.9 percent, respectively, while perceptions that biotechnology is risky lowers trust 
by nearly 10 percent.  Moreover, expectations of trustworthiness appear to be particularly 
important for trust in food manufacturers.  For example, respondents who believe that the 
biotechnology industry can regulate itself (e.g., that it is trustworthy) show a 19 percent 
improvement in trust in food manufacturers, relative to respondents who do not believe the 
industry can self-regulate.  Finally, expectations of competence also appear to be important for 
trust in food manufacturers, suggested by the finding that respondents who believe it is not worth 
labeling GM foods – perhaps because they are not concerned enough about the competence of 
biotechnology institutions to worry about the need to distinguish between GM and non-GM 
foods – are 19 percent more likely to trust food manufacturers than respondents who believe GM 
foods should be labeled. 
Table 3 shows that trust in scientists and food manufacturers has an important effect on 
public support for biotechnology, even after controlling for the endogeneity of trust as well as 
other factors expected to affect public support.  Indeed, of the variables included in this analysis, 
trust has the largest effect on public support.  For instance, based on results reported as Model 1, 
which examines the effect of trust of scientists, a one standard deviation in the trust of scientists 
improves public support for biotechnology by 41 percent.  Similarly, the results reported as 
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Model 2, which examines the effect of trust of food manufacturers, indicate that a one standard 
deviation in trust in food manufacturers improves public support by nearly 23 percent.  The 
statistically insignificant effect of trust in scientists in Model 3 is likely due to multicollinearity 
between trust in scientists and trust in food manufacturers.  Nevertheless, the magnitudes of the 
estimated coefficients are still large relative to the other reported variables. 
Interestingly, the analysis shows that trust in scientists appears to have a comparatively 
larger effect on public support for biotechnology than trust in food manufacturers, even as few 
factors affect that trust (see Table 2). Additionally, perceptions that biotechnology is risky result 
in lower public support, as do negative feelings for biotechnology.  In contrast, respondents who 
believe biotechnology is important, who are informed about biotechnology, or who have a basic 
understanding of the science of biotechnology (e.g., genetics) are more likely to support 
biotechnology. 
 
Discussion 
This study finds that only perceived benefits and expectations of trustworthiness affect 
trust in scientists, while variables reflecting perceived benefits and costs, and expectations of 
trustworthiness and competence, collectively explain trust in food manufacturers.  The fact that 
fewer variables are correlated with trust in scientists than with trust in food manufacturers, and 
that trust in scientists seems to have a stronger effect on public support for biotechnology than 
trust in food manufacturers, is curious. One possible explanation is based on Uslaner's (2002) 
distinction between generalized and particularized trust.  Generalized trust is trust placed in most 
people; it is relatively stable and is largely unaffected by other factors, such as regression 
covariates.  This is in contrast to particularized trust, which is trust placed in specific institutions 
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or institutions associated with certain characteristics.  As such, particularized trust would be 
affected by institutions or individual characteristics and hence would be relatively more affected 
by covariates than generalized trust. This characterization fits the data presented here.  The data 
reveal not only that few variables (e.g., only two in this study) are correlated with trust in 
scientists, but also that most people trust scientists, particularly when compared to trust of food 
manufacturers.  Thus, trust in scientists might be relatively more generalized than trust in food 
manufacturers. 
According to Uslaner (2002), generalized trust is important for the development of social 
capital, which in turn is necessary for the functioning of democratic and market-oriented 
societies.  Thus, if trust in scientists is generalized, then trust in scientists should have important 
benefits to society generally, especially in the context of potentially controversial issues such as 
biotechnology research and applications to food, medicine and other consumer products.  The 
data appear to be consistent with this argument. Trust in scientists has a comparatively larger 
effect on public support for biotechnology than trust in food manufacturers (see Table 3). This 
will likely have important implications for the public support of biotechnology, since 
information the public receives about biotechnology often comes from the scientists engaged in 
the research.  This is also consistent with previous scholarship showing that scientists are 
regarded by both the public and other scientists as most likely to tell the truth about 
biotechnology (see Lang, O'Neill, and Hallman, 2004).  Hence, even if there are negative stories 
about biotechnology (e.g., reports of GM contamination of non-GM foods or crops), information 
reported by scientists might still be regarded as reliable.  
Even though trust in scientists is generalized, trust in food manufacturers is affected by a 
full range of variables reflecting public perceptions of risks and benefits, as well as perceptions 
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of trustworthiness and competence.  This makes sense, since it is from food manufacturers that 
we get our food.  Consumers are closer to food manufacturers than to scientists along the value 
chain, suggesting that public perceptions ought to be more salient in the case of food 
manufacturers than for scientists.  Importantly, this study has shown that perceptions of 
trustworthiness and competence are particularly important for trust in food manufacturers.  As 
explained above, perceptions of trustworthiness and competence are necessary for trust 
formation, meaning that if absent, trust will not exist.  For instance, public announcements of 
biotechnology problems (such as GM contamination of human food products) can have negative 
impacts on trust, even though the trustworthiness of biotechnology institutions is not an issue.  
Conversely, questions of trustworthiness, which might arise because of corporate accounting 
scandals of both biotechnology and non-biotechnology companies, could also destroy trust.  This 
supports Slovic's (1993) argument that a negative announcement can destroy trust quickly, but 
building trust is difficult because it takes time.   
This study has also shown that trust in scientists and food manufacturers has a large and 
important effect on public support for biotechnology.  Indeed, trust is shown to be more 
important than perceptions of risks or benefits alone.  Given the inevitably increasing scientific 
advances of biotechnology research, an understanding of the relationship between trust and 
public support is important in guiding the social debate over GM foods and the role of 
biotechnology in food production.  Risk assessment and communication will matter little if 
public trust in biotechnology institutions is lacking.  
Recognizing this is essential for post-market surveillance of GM foods, for instance (see 
Health Canada, 2002). In developing an infrastructure for conducting post-market surveillance, 
effort should not be placed exclusively on determining the processes by which we assess the 
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human health effects of new technologies, particularly those involving biotechnology and GM 
foods. Rather, the social impacts of conducting post-market surveillance must also be 
recognized. The reason is that the formation or destruction of public trust in biotechnology 
institutions will be directly related to the processes and outcomes of post-market surveillance, 
because these affect public perceptions of the trustworthiness and competence of biotechnology 
institutions in addition to the perceived risks and benefits of biotechnology research.  For 
example, suppose post-market surveillance repeatedly reveals no adverse health effects of certain 
GM foods. Over time, public perceptions of the competence of biotechnology institutions would 
likely be reinforced, thus resulting in increased public trust and, consequently, public support for 
biotechnology applications in food production. Suppose, on the other hand, it is revealed that 
certain GM foods pose health risks and that biotechnology institutions (or government 
regulators) have systematically concealed these risks to the public. Public trust in biotechnology 
institutions would become seriously eroded because of a reduction in the perceived 
trustworthiness of biotechnology institutions, thus resulting in a decrease in public support for 
biotechnology – and this would be independent of the actual risks and benefits of GM foods.  
Clearly, more research is necessary in order to understand the mechanisms by which 
public trust in biotechnology institutions is created and destroyed, especially since trust has such 
a strong effect on public support.  For instance, one avenue of research is examining the 
processes by which risks and benefits of biotechnology are communicated to the public in 
addition to who does the communicating.  Does the process of communicating have an important 
effect on trust formation?  If so, then by implication it will have an important effect on public 
support. Another direction is to examine more recent data on public attitudes towards 
biotechnology in different contexts, such as comparing European attitudes to those of Americans. 
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Table 1. Sample Means and Standard Deviations of Dependent and Independent Variables 
Variable Definitions Mean St. Dev 
     Dependent Variables 
Trust scientists Dichotomous variable equal to one if respondent placed a lot or some trust 
in a statement by university scientists about biotechnology. 0.9035 0.2955 
Trust food 
manufacturers 
Dichotomous variable equal to one if respondent placed a lot or some trust 
in a statement by food manufacturers about biotechnology.  0.5511 0.4976 
Support biotechnology Dichotomous variable equal to one if respondent expressed support (rather 
than opposition) to biotechnology in agriculture and food production.  0.7516 0.4323 
     Variables in Trust Model 
Will improve life Dummy variable equal to one if respondent believe biotechnology or 
genetic engineering will improve our way of life.  0.5989 0.4904 
Will reduce 
environmental 
pollution 
Dummy variable equal to one if respondent believes biotechnology will 
likely reduce environmental pollution within the next 20 years.  0.6073 0.4886 
Will reduce world 
hunger 
Dummy variable equal to one if respondent believes  biotechnology will 
likely reduce world hunger.  0.4827 0.4999 
Too risky Dummy variable equal to one if respondent definitely agreed or tended to 
agree that each of the following are risky for society: use of biotechnology 
in food and drink; inserting genes from plants to crops; and introducing 
human genes into animals.  
0.2371 0.4255 
Likely result in new 
diseases 
Dummy variable equal to one if respondent believes biotechnology will 
likely result in new diseases within the next 20 years.  0.6514 0.4768 
Likely reduce range of 
foods 
Dummy variable equal to one if respondent believes biotechnology will 
likely reduce the range of fruits and vegetables we can get.  0.4114 0.4923 
Current regulations 
sufficient 
Dummy variable equal to one if respondent strongly agrees or agrees that 
current regulations are sufficient to protect people from risks of 
biotechnology. 
0.3702 0.4831 
Industry can self-
regulate 
Dummy variable equal to one if respondent strong agrees or agrees that the 
biotechnology industry can regulate itself. 0.1921 0.3942 
Too complex for policy Dummy variable equal to one if respondent strongly agrees or agrees that 
biotechnology is too complicated to be sufficiently regulated.  0.1715 0.3771 
Not worth labeling Dummy variable equal to one if respondent strongly agree or agree that it is 
not worth putting labels on genetically modified foods.  0.1603 0.3670 
     Variables in Support Model 
Religious Scale variable ranging from 0 to 10, based on respondent assessment of 
how religious he is, where 0 is not at all religious and 10 is very religious. 6.3330 2.7709 
Biotechnology is 
important 
Scale variable ranging from 0 to 10, based on respondent assessment of 
how important biotechnology is to oneself, where 0 is not at all important 
and 10 is extremely important.  
7.2110 2.0132 
Informed about 
biotechnology 
Scale variable ranging from 0 to 10, based on respondent assessment of 
how informed he is about biotechnology, where 0 means not at all 
informed and 10 means very well informed.  
4.6792 1.9765 
Negative feelings about 
biotechnology 
Dummy variable equal to one if the respondent has strongly negative or 
negative feelings about modern biotechnology.  0.1425 0.3497 
Understanding of  basic 
genetics 
Dummy variable equal to one if the respondent correctly answered each of 
the following questions: (1) DNA regulates inherited characteristics in all 
plants, animals, and humans (correct answer true); (2) Given today's 
biotechnology, scientists can now create new genes that never existed in 
nature (false); (3) Ordinary tomatoes do not contain genes while genetically 
modified tomatoes do (false); and (4) By eating a genetically modified 
fruit, a person's genes could also become modified (false); and (5) It is 
impossible to transfer animal genes into plants (false).  
0.0450 0.2074 
     Control Variables for Trust and Support Models 
College Dummy variable equal to one if the respondent had some college 
education.  0.5867 0.4927 
Male Dummy variable equal to one if the respondent is male.  0.4977 0.5002 
Married Dummy variable equal to one if the respondent was married.  0.5473 0.4980 
Age Respondent age.  44.6572 15.5541 
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Table 2. Probit regression of trust in scientists and trust in food manufacturers. 
 Trust in Scientists  Trust in Food 
Manufacturers 
Variable Coefficient 
(St. Error) 
Est. Slope  Coefficient 
(St. Error) 
Est. Slope 
Intercept 1.1882**
(0.4915) 
 
0.1914 
 
 -0.4762 
(0.3540) 
 
-0.1716 
 
Will improve life 0.3057***
(0.1140) 
 
0.0492 
 
 0.2434***
(0.0845) 
 
0.0871 
 
Will reduce environmental 
pollution 
0.1264 
(0.1169) 
 
0.0204 
 
 0.1550*
(0.0860) 
 
0.0559 
 
Will reduce world hunger 0.0347 
(0.1189) 
 
0.0056 
 
 0.2746***
(0.0855) 
 
0.0990 
 
Too risky -0.1960 
(0.1244) 
 
-0.0316 
 
 -0.2758***
(0.0969) 
 
-0.0994 
 
Likely result in new 
diseases 
-0.1031 
(0.1245) 
 
-0.0166 
 
 -0.0952 
(0.0879) 
 
-0.0343 
 
Likely reduce range of 
foods 
-0.0322 
(0.1143) 
 
-0.0052 
 
 -0.0066 
(0.0841) 
 
-0.0024 
 
Current regulations 
sufficient 
0.3428***
(0.1308) 
 
0.0552 
 
 0.2633***
(0.0883) 
 
0.0949 
 
Industry can self-regulate 0.0643 
(0.1545) 
 
0.0104 
 
 0.5393***
(0.1137) 
 
0.1944 
 
Too complex for policy -0.1603 
(0.1420) 
 
-0.0258 
 
 -0.1166 
(0.1109) 
 
-0.0420 
 
Not worth labeling 0.1286 
(0.1641) 
 
0.0207 
 
 0.2400**
(0.1141) 
 
0.0865 
 
College 0.0433 
(0.1159) 
 
0.0070 
 
 -0.1403*
(0.0848) 
 
-0.0506 
 
Male -0.1412 
(0.1123) 
 
-0.0227 
 
 0.0813 
(0.0815) 
 
0.0293 
 
Married 0.0274 
(0.1161) 
 
0.0044 
 
 0.0378 
(0.0855) 
 
0.0136 
 
Age 0.0035 
(0.0204) 
 
0.0006 
 
 0.0041 
(0.0150) 
 
0.0015 
 
Age squared -0.0001 
(0.0002) 
 
-0.00002 
 
 0.0000 
(0.0002) 
 
0.0000 
 
Pseudo R-square  
Likelihood ratio (df=15) 
% correctly predicted 
Ave Density 
0.0706 
35.5065***
66.6 
0.1611 
  0.1427 
119.3660***
68.2 
0.3604 
 
Standard errors in parentheses. Estimated slope calculated by multiplying coefficient with average density.  
*** significant at 1%; ** significant at 5%; * significant at 10% 
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Table 3. Probit analysis of support of biotechnology, controlling for trust and other factors. 
 Model 1  Model 2  Model 3 
Variable Coefficient 
(St. Error) 
Est. Slope  Coefficient 
(St. Error) 
Est. Slope  Coefficient 
(St. Error) 
Est. Slope 
Intercept -4.2728***
(1.2894) 
 
-1.1374 
 
 -0.4284 
(0.4677) 
 
-0.1137 
 
 -1.9287 
(1.6198) 
 
-0.5109 
 
Trust scientists (predicted) 5.2128***
(1.3203) 
 
1.3876 
 
  
 
 
 
 
 1.8597 
(1.9234) 
 
0.4926 
 
Trust food manufacturers 
(predicted) 
 
 
 
 
 
 1.7134***
(0.3822) 
 
0.4546 
 
 1.3237**
(0.5556) 
 
0.3506 
 
Will improve life 0.0611 
(0.1247) 
 
0.0163 
 
 0.1755*
(0.1059) 
 
0.0466 
 
 0.1093 
(0.1259) 
 
0.0290 
 
Too risky -0.3679***
(0.1197) 
 
-0.0979 
 
 -0.3896***
(0.1134) 
 
-0.1034 
 
 -0.3522***
(0.1199) 
 
-0.0933 
 
Religious -0.0112 
(0.0174) 
 
-0.0030 
 
 -0.0171 
(0.0175) 
 
-0.0045 
 
 -0.0156 
(0.0175) 
 
-0.0041 
 
Biotechnology is important 0.0645***
(0.0251) 
 
0.0172 
 
 0.0691***
(0.251) 
 
0.0183 
 
 0.0672***
(0.0252) 
 
0.0178 
 
Informed about 
biotechnology 
0.0999***
(0.0259) 
 
0.0266 
 
 0.1014***
(0.0261) 
 
0.0269 
 
 0.1017***
(0.0261) 
 
0.0269 
 
Negative feelings about 
biotechnology 
-0.2963**
(0.1264) 
 
-0.0788 
 
 -0.2946**
(0.1262) 
 
-0.0782 
 
 -0.2916**
(0.1264) 
 
-0.0772 
 
Understanding of  basic 
genetics 
0.6121**
(0.2795) 
 
0.1629 
 
 0.5986**
(0.2784) 
 
0.1588 
 
 0.6027**
(0.2792) 
 
0.1597 
 
College 0.1077 
(0.0946) 
 
0.0287 
 
 0.2707***
(0.0997) 
 
0.0718 
 
 0.2307**
(0.1078) 
 
0.0611 
 
Male 0.3429***
(0.0982) 
 
0.0913 
 
 0.1759*
(0.0956) 
 
0.0467 
 
 0.2271**
(0.1096) 
 
0.0602 
 
Married 0.0116 
(0.0985) 
 
0.0031 
 
 0.0133 
(0.0985) 
 
0.0035 
 
 0.0062 
(0.0989) 
 
0.0016 
 
Age -0.0395**
(0.0177) 
 
-0.0105 
 
 -0.0365**
(0.0178) 
 
-0.0097 
 
 -0.0365**
(0.0178) 
 
-0.0097 
 
Age squared 0.00049***
(0.00018) 
 
0.00013 
 
 0.00036***
(0.00018) 
 
0.00010 
 
 0.00039**
(0.00019) 
 
0.00010 
 
Pseudo R-square 
Likelihood ratio (df=13) 
% correctly predicted 
Ave Density 
0.2128 
158.7074***
75.4 
0.2662 
  0.2188 
163.5604***
75.4 
0.2653 
  0.2199 
164.4992***
75.5 
0.2649 
 
Standard errors in parentheses. Estimated slope calculated by multiplying coefficient with average density.  
*** significant at 1%; ** significant at 5%; * significant at 10% 
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